New Algorithm Breaks Dijkstra's Time Complexity for Directed Shortest Paths
By
pentestercrab
A weekday bagel. Dependable, satisfying, no fuss.
Summary
The article presents a deterministic algorithm for single-source shortest paths (SSSP) on directed graphs with real non-negative edge weights, achieving a time complexity of $O(m\log^{2/3}n)$. This breakthrough surpasses the long-standing $O(m+n\log n)$ bound of Dijkstra's algorithm, demonstrating its non-optimality for SSSP on sparse graphs.
Key quotes
· 2 pulledThis is the first result to break the $O(m+n\log n)$ time bound of Dijkstra's algorithm on sparse graphs.
We give a deterministic $O(m\log^{2/3}n)$-time algorithm for single-source shortest paths (SSSP) on directed graphs with real non-negative edge weights.
You might also wanna read
German study finds POLO back-junction solar cells more cost-effective than PERC technology in Europe
A German research team from the German Aerospace Center (DLR) conducted a techno-economic analysis of POLO back-junction (BJ) solar cells in
AI-powered whale detection system deployed in San Francisco Bay to prevent ship collisions
A new AI-powered whale detection system is being deployed in San Francisco Bay to prevent ship collisions with whales. The system uses under
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Gabe Newell funds $815 million deep-sea research vessel to explore uncharted ocean depths
Gabe Newell, billionaire co-founder of Valve and Steam, is funding the construction of the RV11000, a massive $815 million deep-sea research
luxurylaunches.com·50m agoAI-Powered WildObs Platform Accelerates Australian Wildlife Conservation Data Analysis
Researchers at The University of Queensland, in partnership with ARDC, QCIF Digital Research, and TERN, have developed the Wildlife Observat
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
